Search Within

Genitourinary Oncology Service

  1. "Andrea Knezevic"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (27)
  3. Research Letter (1)
Groups
  1. Department of Medicine (65)
  2. Solid Tumor Oncology Division (65)
  3. Hematology-Oncology Fellows (58)
  4. Weinberg Fellows (58)
  5. Population Sciences Research Program (35)
  6. Epidemiology and Biostatistics (32)

More Groups

People
  1. Andrea Knezevic (65)
  2. Darren Feldman (52)
  3. Robert Motzer (48)
  4. Martin Voss (39)
  5. Chung-Han Lee (33)
  6. Maria Carlo (31)

More People

Years
  1. 2025 (8)
  2. 2024 (13)
  3. 2023 (9)
  4. 2022 (11)
  5. 2021 (5)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Clinical Genitourinary Cancer (4)
  3. Cancer (3)
  4. European Urology (3)
  5. Clinical Cancer Research (2)
  6. European Urology Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (40)
  2. Elsevier Inc. (4)
  3. Elsevier Science, Inc. (4)
  4. Wiley Blackwell (4)
  5. American Association for Cancer Research (3)
  6. Elsevier BV (3)

More Publishers

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Automated portal-enabled elicitation of health-related patient values in solid tumor oncology: Feasibility and patient characteristics associated with patient response
    Journal Article

    Epstein, A. S.; Knezevic, A.; Hoque, A.; Rosa, W. E.; Harding, J. J.; Raj, N.; Reidy, D.; Iyer, G. V.; Applebaum, A. J.; Nelson, J. E.
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • KEAP1 mutated renal cell carcinoma (RCC): Characterization of an emerging molecularly defined RCC subtype
    Meeting Abstract

    Carlo, M.; Chen, Y. B.; Knezevic, A.; Zong, G.; Bakouny, Z.; Kemel, Y.; Latham, A.; Liu, Y. L.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • STARLITE 2: Phase 2 study of nivolumab plus (177)lutetium-labeled anti-carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab ((177)Lu-girentuximab) in patients with advanced clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Feldman, D. R.; Motzer, R. J.; Knezevic, A.; Voss, M. H.; Lyashchenko, S. K.; Park, H.; Larson, S. M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Local definitive therapy (LDT) utilization patterns and outcomes in chromophobe renal cell carcinoma (chRCC) with metachronous metastasis: A multi-institution study
    Meeting Abstract

    Dizman, N.; Doshi, S. D.; Knezevic, A.; Feinaj, A.; Sayegh, N.; Hobeika, C.; Alaghehbandan, R.; Rives, H.; Zengin, Z. B.; Braun, D. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical outcomes and targeted genomic analysis of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Journal Article

    Ma, J.; del Balzo, L.; Walch, H.; Khaleel, S.; Knezevic, A.; Flynn, J.; Zhang, Z.; Eichholz, J.; Doshi, S. D.; Voss, M. H.; more...
    European Urology Oncology (2025)

    Fulltext@MSK | Save
  • Sample site impacts RNA biomarkers for renal cell carcinoma
    Journal Article

    Eismann, L.; Xie, A. X.; Tang, C.; Knezevic, A.; Ostrovnaya, I.; Kuo, F.; Ari Hakimi, A.; Reznik, E.; Kotecha, R. R.
    European Urology (2025)

    Fulltext@MSK | Save
  • Prospective study of patient, nursing, and oncology provider perspectives on telemedicine visits for renal cell carcinoma clinical trials
    Journal Article

    Doshi, S. D.; Knezevic, A.; Gonzalez, C.; Fischer, P.; Goodman, R.; Gornell, S.; Patel, S.; Puzio, C.; Ritea, A.; Lee, C. H.; more...
    Clinical Genitourinary Cancer (2025)

    Fulltext@MSK | Save
  • Validation of automated bone scan index as a progression endpoint in two phase III studies of metastatic castration resistant prostate cancer (mCRPC) patients
    Meeting Abstract

    Knezevic, A.; Heller, G.; Sjöstrand, K.; Anand, A.; Borzillo, G.; Larson, S.; Morris, M. J.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection
    Journal Article

    Baky, F.; Liso, N.; Williams, B.; Knezevic, A.; Funt, S. A.; Feldman, D. R.; Carver, B.; Sheinfeld, J.; Matulewicz, R. S.
    Clinical Genitourinary Cancer (2024)

    Fulltext@MSK | Save